Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01179
Species: Mus musculus
Position : chr11:111456657-111460228
Year: 2020
Title: Loss of Extreme Long-Range Enhancers in Human Neural Crest Drives a Craniofacial Disorder.
Genome Build: mm39
Enhancer Type: Enhancer
Condition: Disease
Disease Name: isolated Pierre Robin sequence
PMID:  32991838
MONDO: MONDO:0009869
Tissue: developing mandible / craniofacial mesenchyme
Tissue Ontology ID: UBERON:0001684
Cell Source: Human cranial neural crest cells plus endogenous orthologous mouse EC1.45 deletion models
Cell Type: cranial neural crest cell
Cell Ontology ID: CL:0000333
Experiment Type: EC1.45/Rr80 extreme long-range enhancer cluster; TWIST1 occupancy; Capture-C target assignment; endogenous orthologous enhancer deletion; craniofacial phenotyping
High Throughput Method: p300/H3K27ac ChIP-seq; ATAC-seq; Capture-C
Low Throughput Method: Luciferase reporter; CRISPR-Cas9 EC1.45 deletion; allele-specific RT-ddPCR; mouse lacZ reporter; in situ hybridization; Coordinator-motif deletion
About Target Gene
Target gene : Sox9
About TF
TF name : Twist1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Twist1 HIF-2-alpha transcription factor network pid 34
Twist1 Notch-mediated HES/HEY network pid 48
Twist1 Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
Twist1 Hs_miR-509-3p_alteration_of_YAP1-ECM_axis_WP3967_91491 wikipathways 14
Twist1 Hs_G13_Signaling_Pathway_WP524_72112 wikipathways 18
Twist1 Hs_Transcription_factor_regulation_in_adipogenesis_WP3599_88581 wikipathways 9
Enhancer Associated Network
Overlapping Enhancers (mm39) 2 found
Enhancer ID Position Tissue Cell Disease
E_05375 chr11:111456657-111460228 developing craniofacial mesenchyme / jaw cranial neural crest-derived mesenchymal progenitor NA
E_05376 chr11:111456657-111460228 developing craniofacial mesenchyme / jaw cranial neural crest-derived mesenchymal progenitor NA
Expression of Target Genes for the Enhancer